Evidence map›Paper›PMID 41986903›Full record

ArticlePest management science2026

Fitness costs associated with Vip3Aa resistance on various hosts in Helicoverpa zea.

Haley Kennedy, David L Kerns, Graham P Head, Fei Yang

Abstract read
In one paragraph

Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Haley KennedyDepartment of Entomology, Texas A&M University, College Station, TX, USA.
David L KernsDepartment of Entomology, Texas A&M University, College Station, TX, USA.
Graham P HeadBayer Crop Science, St. Louis, MO, USA.
Fei YangDepartment of Entomology, University of Minnesota, Saint Paul, MN, USA.

Funding

Bayer CropScience: RM 2201.USDA National Institute of Food and Agriculture: Biotechnology Risk Assessment Research Grants Program 2020-33522-32318/project accession no. 1023784
6 · The paper itself

Abstract

backgroundTransgenic crops containing Bacillus thuringiensis (Bt) proteins are crucial for managing major agricultural pests such as the corn earworm, Helicoverpa zea (Boddie). The fitness of Bt resistant insects on refuge crops plays an important role in determining the rate of resistance development. Previous research has investigated the fitness costs of Cry1 and Cry2 resistance in H. zea, but limited information is available about the fitness costs associated with Vip3Aa resistance in this pest. Here, we evaluated fitness costs of Vip3Aa-resistant H. zea on three non-Bt hosts: meridic diet, corn ears, and cotton leaves.

resultsOn meridic diet, we detected recessive fitness costs resulting in lower survival and fecundity, and dominant fitness costs resulting in longer developmental time and reduced egg hatching rates. On corn ears, we observed recessive fitness costs resulting in lower pupal mass, and dominant fitness costs resulting in lower survival and fecundity, longer developmental time, and reduced egg hatching rates. On cotton leaves, we found recessive fitness costs resulting in lower female pupal mass, and dominant fitness costs resulting in lower adult survival and fecundity, and longer developmental time.

conclusionSignificant differences in survivorship, developmental time, pupal mass, and reproduction among the Vip3A-resistant (RR), -susceptible (SS) and -heterozygous (R

Indexed as

Bacterial ProteinsGenetic FitnessInsecticide ResistanceMothsAnimalsFemaleFertilityGossypiumLarvaPlants, Genetically ModifiedPupaZea maysBacterial ProteinsVip3A protein, Bacillus thuringiensisBacillus thuringiensisfitness costHelicoverpa zearesistanceVip3A

Identifiers

PMID41986903
PMCPMC13352236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.